Last year, Sean Slovenski left Walmart to join a company in the world of diagnostics at a time when the industry became front and center to managing the Covid-19 pandemic. From his perch as president of Walmart Health, Slovenski realized that the traditional players had proved unequal to the task of mass and pervasive task.
So he decided to jump ship and landed as CEO of BioIQ, an Atlanta-based diagnostics service company whose founder he had known for years. In MedCity’s latest Pivot podcast episode, Slovenski describes why he believes the diagnostic industry failed in testing last year and how he imagines a world without labs altogether. Listen below.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
